First Opinion Klaudia Jaźwińska Implant recipients shouldn’t be left in the dark when a device maker cuts off support
First Opinion Philip Krause and Luciana L. Borio Will low-dose vaccination stretch the monkeypox vaccine supply, or backfire?
First Opinion Hans Gutbrod Addressing institutional trauma in health care: the case for a structured ethical framework
First Opinion Maimah Karmo Triple-negative breast cancer highlights the need to act against health inequities
First Opinion Martha Rebour and Purvi Parikh The U.S. must fully fund global polio eradication efforts
First Opinion Standish Fleming The outsized effect of ‘modest’ price controls on pharmaceutical innovation
First Opinion Ken Frazier Addressing social drivers of health is a big opportunity for tech entrepreneurs
First Opinion Dana P. Goldman, Edith A. Perez and Carlos del Rio Lack of diversity in clinical trials costs billions of dollars. Incentives can spur innovation
First Opinion Lawrence O. Gostin, Kevin A. Klock and Sam F. Halabi Inching closer to an essential global pandemic treaty
First Opinion Victor Wang Hospitals, health systems play critical roles in the real-world data movement
First Opinion David Blumenthal Keeping climate provisions in the budget reconciliation act is a key step toward protecting Americans’ health
First Opinion Stephen Bohan Americans deserve better than ‘destination hallway’ in emergency departments and hospital wards
First Opinion Kenneth E. Thorpe WTO: Don’t make a bad situation worse by granting intellectual property waivers for Covid-19 therapeutics and diagnostics
First Opinion David Reese and Kári Stefánsson A better understanding of human diversity is needed to equitably advance precision medicine
First Opinion Quita Highsmith I learned up close and personal about the necessity of improving diversity in clinical trials
First Opinion Irene Shapiro The Morris ALS Principles: A model for empowering all disease communities
First Opinion Kip Sullivan, Ana Malinow and Kay Tillow Value-based payment has produced little value. It needs a time-out
First Opinion Christine Bechtel, Lois Frankel and Jennifer Sweeney Clinician-administrator relationships are ‘on life support.’ Here’s how to heal them
First Opinion Kira Sampson, Carlise Sorenson and Kate Adamala The FDA needs to get ready to evaluate synthetic cells, the next generation of therapeutics
First Opinion Reuben Guttman and Liza Vertinsky Demanding more impact from impact litigation: lessons to be learned from multi-state opioid settlements
First Opinion Jeeshan Chowdhury Working with Indigenous allies is the ethical way to develop psychedelic-based pharmaceuticals
First Opinion Thomas B. Cueni and Richard Hatchett Poorer nations need assurances of dedicated vaccine supplies before the next pandemic
First Opinion Katherine A. Gergen-Barnett and Russell S. Phillips Deal between Amazon and One Medical has massive implications for the future of primary care
First Opinion Craig Garthwaite Drug price controls are a dance with the devil: short-term savings will be overwhelmed by loss of innovation